Early-Warning Intervention for Heat and Cold in Older Hypertensive Patients: Impact on Sleep Quality
Early-warning Intervention for Heat and Cold in Older Hypertensive Patients: Impact on Sleep Quality
1 other identifier
interventional
378
1 country
1
Brief Summary
This cluster-randomized trial, conducted in Tianjin, China, aims to evaluate the effectiveness of integrating a digital health risk early warning tool for heat with self-monitoring. Additionally, the study assesses the effectiveness of combining a digital health risk early warning tool for cold with self-monitoring. Communities from three districts will be randomly assigned to one of three groups: the combined intervention group, the self-monitoring group, and the control group. The primary objective of the study is to evaluate the effectiveness of the intervention in improving sleep quality, as well as understanding its underlying biological mechanisms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hypertension
Started Jul 2023
Shorter than P25 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2023
CompletedFirst Submitted
Initial submission to the registry
September 10, 2023
CompletedFirst Posted
Study publicly available on registry
September 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2024
CompletedOctober 30, 2024
October 1, 2024
8 months
September 10, 2023
October 25, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Change from baseline in the PSQI score
The PSQI score is measured by the pittsburgh sleep quality index questionnaire. The PSQI consists of 19 individual items that assess seven key components of sleep: subjective sleep quality, sleep latency (the time it takes to fall asleep), sleep duration, habitual sleep efficiency (the ratio of total sleep time to time spent in bed), sleep disturbances, use of sleep medication, and daytime dysfunction.Each of the seven components is scored from 0 to 3, with the total PSQI score ranging from 0 to 21. A total score greater than 5 indicates poor sleep quality, while a lower score suggests good sleep quality.
baseline, six months
Secondary Outcomes (25)
Change from baseline in the control rate of blood pressure (SBP/DBP <140/90 mm Hg)
baseline, six months
Change from baseline in the risk of the overall warning level for abnormal ECG.
baseline, six months
Change from baseline in the control rate of blood pressure (SBP/DBP <120/80 mm Hg)
baseline, six months
Change from baseline in SBP
baseline, six months
Change from baseline in DBP
baseline, six months
- +20 more secondary outcomes
Study Arms (3)
Combined intervention
EXPERIMENTALParticipants in the combined intervention group will receive real-time health risk warnings for heat waves and cold spells via a WeChat mini-program and will perform daily self-monitoring of BP and ECG using automated home devices.
Self-monitoring alone
EXPERIMENTALControl
NO INTERVENTIONInterventions
Whenever a health risk warning for a heat or cold is issued, only the elderly in the combined intervention group will be alerted to the early warning information through the digital heat or cold health risk early warning tool.
A WeChat mini-program provides real-time updates on early warnings and health advisories.
Participants in the self-monitoring alone group were instructed to self-measure their BP three times each morning (from 6:00 a.m. to 8:00 a.m.) and evening (from 6:00 p.m. to 8:00 p.m.) at home, and to self-administer ECG measurements twice during the same morning and evening timeframes.
Devices for self-monitoring blood pressure and electrocardiography (ECG).
Eligibility Criteria
You may qualify if:
- Individuals aged 60 to 65 years Individuals with a diagnosis of hypertension Individuals with untreated blood pressure above 140/90 mm Hg
You may not qualify if:
- Having a history of coronary heart disease, heart failure, or stroke Unable to cooperate with follow-up
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tiantian Lilead
Study Sites (1)
National Institute of Environmental Health, Chinese Center for Disease Control and Prevention
Beijing, 100021, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Tiantian Li
National lnstitute of Environmental Health, Chinese Center for Disease Controland Prevention
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- professor
Study Record Dates
First Submitted
September 10, 2023
First Posted
September 21, 2023
Study Start
July 1, 2023
Primary Completion
February 28, 2024
Study Completion
February 28, 2024
Last Updated
October 30, 2024
Record last verified: 2024-10